COWEN AND COMPANY, LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,129,113
+86.0%
4,308,359
+38.2%
1.34%
+56.9%
Q2 2023$10,286,086
+65.9%
3,116,996
+43.2%
0.85%
+17.2%
Q1 2023$6,201,728
-37.4%
2,176,045
+59.9%
0.73%
-29.7%
Q4 2022$9,909,310
-47.8%
1,361,169
-42.0%
1.04%
-43.0%
Q3 2022$18,995,000
+62.5%
2,347,989
-1.6%
1.82%
+60.9%
Q2 2022$11,691,000
-85.7%
2,385,885
-30.9%
1.13%
-85.6%
Q1 2022$81,672,000
+85.5%
3,453,371
+121.3%
7.86%
+276.8%
Q3 2021$44,023,000
+218.3%
1,560,563
+18.2%
2.09%
+188.9%
Q2 2021$13,832,000
+33.2%
1,319,887
+49.7%
0.72%
+1.1%
Q1 2021$10,388,000881,8320.71%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders